Contact Medicilon

Contact Us

Name(Required)
Address(Required)

Search Medicilon

【Case Study】New Approach Methods NAMs

Medicilion Congratulates MediLink Therapeutics on Licensing B7H3 ADC to Roche

Medicilion Congratulates MediLink Therapeutics on Licensing B7H3 ADC to Roche

AACR 2026

Contact Medicilon

Name(Required)
Address(Required)